See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626878_2024_Xbiotech_Inc.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -32000} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.0007540234218526, 'aggregate_val': -32000, 'exp_sum': 42439000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 4714000, 'ResearchAndDevelopmentExpense': 37757000, 'remainder_Expenses': -32000}} |
Graph
Absolute values for 0001626878, Xbiotech Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 201,718,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 24,897,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 6,100,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,669,000 |
| 7 | CostOfGoodsAndServicesSold | 191,831 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,045,470 |
| 9 | ResearchAndDevelopmentExpense | 32,527,902 |
| 10 | remainder_Expenses | -42,905 |
| 11 | remainder_Revenues | 803,673 |
| 12 | remainder_NetIncome | 8,997,675 |
| 13 | remainder_ComprehensiveNetIncome | -845,672 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 226,615,000 |
| 1 | Liabilities | 7,769,000 |
| 2 | Expenses | 37,722,298 |
| 3 | Revenues | 803,673 |
| 4 | StockholdersEquity | 218,846,000 |
| 5 | NetIncome | -27,920,950 |
| 6 | ComprehensiveNetIncome | -28,343,786 |
| 7 | BaseVar | 141,376,659 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.83 |
| 9 | EconomicCapitalRatio | 4.27 |
Edgar->Model Mapping
Feature Distribution
Change over Time
